M. Bruniaux

Kinetics of mouse jejunum radiosensitization by 2′,2′-difluorodeoxycytidine (gemcitabine) and its relationship with pharmacodynamics of DNA synthesis inhibition and cell cycle redistribution in crypt cells

V. Grégoire, P. Scalliet, M. Beauduin, 1997, British Journal of Cancer.

The effect of 2'-2' difluorodeoxycytidine (dFdC, gemcitabine) on radiation-induced cell lethality in two human head and neck squamous carcinoma cell lines differing in intrinsic radiosensitivity.

V. Grégoire, B. D. De Coster, P. Scalliet, 1999, International journal of radiation biology.

Radiosensitization of mouse sarcoma cells by fludarabine (F-ara-A) or gemcitabine (dFdC), two nucleoside analogues, is not mediated by an increased induction or a repair inhibition of DNA double-strand breaks as measured by pulsed-field gel electrophoresis.

V. Grégoire, B. D. De Coster, P. Scalliet, 1998, International journal of radiation biology.

Role of deoxycytidine kinase (dCK) activity in gemcitabine's radioenhancement in mice and human cell lines in vitro.

V. Grégoire, B. D. De Coster, P. Scalliet, 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Lipoprotein concentrations in newborns are associated with allelic variations in their mothers.

O. Descamps, F. Heller, R. Tonglet, 2004, Atherosclerosis.

Role of 2'-2' difluorodeoxycytidine (gemcitabine)-induced cell cycle dysregulation in radio-enhancement of human head and neck squamous cell carcinomas.

V. Grégoire, M. Beauduin, M. Octave-Prignot, 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Kinetics of mouse jejunum radiosensitization by 2',2'-difluorodeoxycytidine (gemcitabine) and its relationship with pharmacodynamics of DNA synthesis inhibition and cell cycle redistribution in crypt cells.

B. D. De Coster, P. Scalliet, M. Beauduin, 1998, British Journal of Cancer.